Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Annals of Nuclear Medicine|November 2, 2020
<sup>131</sup>I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapyRahul V Parghane, Sanjay Talole, Sandip Basu
Clinical Nuclear Medicine|October 4, 2024
Variable Tracer Avidity and Interlesional Heterogeneity on 18 F-FDG, 68 Ga-DOTATATE, and 68 Ga-DOTA-FAPi-04 PET/CT Imaging in a Single Individual Patient With Progressive Metastatic Medullary Thyroid CarcinomaYeshwanth Edamadaka, Rahul V Parghane, Sandip Basu
Clinical Nuclear Medicine|November 25, 2025
Dichotomous Uptake Pattern on [ 18 F]F-FDG and [ 68 Ga]Ga-DOTA-FAPI-04 PET/CT in Lytic, Sclerotic and Marrow Metastatic Skeletal Lesions in Medullary Thyroid CarcinomaShyam Kumar Ravada, Rahul V Parghane, Sandip Basu
Clinical Nuclear Medicine|November 27, 2024
Incidental Detection of Prostatic Lesion on 18 F-FDG PET/CT and 68 Ga-PSMA-11 PET/CT Leading to Diagnosis of Second Primary Prostatic Adenocarcinoma in a Patient of Differentiated Thyroid CancerAbhay Indrasingh Gondhane, Rahul V Parghane, Sandip Basu
Clinical Nuclear Medicine|April 7, 2026
Intramedullary Spinal Cord Metastasis (SCM) From Prostate Carcinoma Detected on [68Ga] Ga-PSMA-11 PET/CTMadhava Reddy Mali, Rahul V Parghane, Sandip Basu
Seminars in Nuclear Medicine|August 10, 2020
Peptide Receptor Radionuclide Therapy of Neuroendocrine TumorsSandip Basu, Rahul V Parghane, Kamaldeep, et al.
Clinical Nuclear Medicine|March 21, 2017
Clinical Response Profile of Metastatic/Advanced Pulmonary Neuroendocrine Tumors to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATERahul V Parghane, Sanjay Talole, Kumar Prabhash, et al.
Nuclear Medicine Communications|February 5, 2024
Evaluation of prostate-specific membrane antigen expression in locally advanced or metastatic breast carcinoma with 68 Ga-PSMA-11 positron-emission tomography/computed tomography imaging for potential theranosticsRahul V Parghane, Tejal Suralkar, Dilip Nikam, et al.
The British Journal of Radiology|October 23, 2020
Long-term outcome of indigenous <sup>177</sup>Lu-DOTATATE PRRT in patients with Metastatic Advanced Neuroendocrine Tumours: a single institutional observation in a large tertiary care settingKeerti Sitani, Rahul V Parghane, Sanjay Talole, et al.
Cancer Medicine|January 7, 2026
Molecular Deconvolution of Circulating "Other Cells": A Reliable Predictive Marker of Therapy Response and Survival in Neuroendocrine Tumor Patients Receiving <sup>177</sup>Lu-DOTATATE PRRTMahesh K Padwal, Rahul V Parghane, Sandip Basu, et al.
Pageof 6